These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Epidemiological and experimental applications to occupational cancer prevention. Vainio H; Hemminki K J UOEH; 1989 Mar; 11 Suppl():323-45. PubMed ID: 2664947 [TBL] [Abstract][Full Text] [Related]
28. Are lifespan rodent carcinogenicity studies defensible for pharmaceutical agents? Monro A Exp Toxicol Pathol; 1996 Feb; 48(2-3):155-66. PubMed ID: 8672869 [TBL] [Abstract][Full Text] [Related]
29. Long-term chemical carcinogenesis bioassays predict human cancer hazards. Issues, controversies, and uncertainties. Huff J Ann N Y Acad Sci; 1999; 895():56-79. PubMed ID: 10676409 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of reduced protocols for carcinogenicity testing of chemicals: report of a joint EPA/NIEHS workshop. Lai DY; Baetcke KP; Vu VT; Cotruvo JA; Eustis SL Regul Toxicol Pharmacol; 1994 Apr; 19(2):183-201. PubMed ID: 8041916 [TBL] [Abstract][Full Text] [Related]
31. The utility of genetically modified mouse assays for identifying human carcinogens: a basic understanding and path forward. The Alternatives to Carcinogenicity Testing Committee ILSI HESI. MacDonald J; French JE; Gerson RJ; Goodman J; Inoue T; Jacobs A; Kasper P; Keller D; Lavin A; Long G; McCullough B; Sistare FD; Storer R; van der Laan JW Toxicol Sci; 2004 Feb; 77(2):188-94. PubMed ID: 14657512 [TBL] [Abstract][Full Text] [Related]
32. The utility of two rodent species in carcinogenic risk assessment of pharmaceuticals in Europe. Van Oosterhout JP; Van der Laan JW; De Waal EJ; Olejniczak K; Hilgenfeld M; Schmidt V; Bass R Regul Toxicol Pharmacol; 1997 Feb; 25(1):6-17. PubMed ID: 9056497 [TBL] [Abstract][Full Text] [Related]
33. The transgenic mouse assay as an alternative test method for regulatory carcinogenicity studies--implications for REACH. Wells MY; Williams ES Regul Toxicol Pharmacol; 2009 Mar; 53(2):150-5. PubMed ID: 19126422 [TBL] [Abstract][Full Text] [Related]
34. How useful are chronic (life-span) toxicology studies in rodents in identifying pharmaceuticals that pose a carcinogenic risk to humans? Monro A Adverse Drug React Toxicol Rev; 1993; 12(1):5-34. PubMed ID: 8513076 [TBL] [Abstract][Full Text] [Related]
35. The results of assays in Drosophila as indicators of exposure to carcinogens. Vogel EW; Graf U; Frei HJ; Nivard MM IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398 [TBL] [Abstract][Full Text] [Related]
36. Identification of rodent carcinogens by an expert system. Rosenkranz HS; Klopman G Prog Clin Biol Res; 1990; 340B():23-48. PubMed ID: 2203007 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. Kirkland D; Aardema M; Henderson L; Müller L Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392 [TBL] [Abstract][Full Text] [Related]
38. An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: II. Identification of genotoxicants, reprotoxicants, and carcinogens using in silico methods. Matthews EJ; Kruhlak NL; Cimino MC; Benz RD; Contrera JF Regul Toxicol Pharmacol; 2006 Mar; 44(2):97-110. PubMed ID: 16352383 [TBL] [Abstract][Full Text] [Related]